retrospective

Brief Communication

Auryon Laser in Treating Symptomatic Infrainguinal Arterial Disease: 1-Year Outcome

06/17/2022

Nicolas W. Shammas, MD, MS¹; Gail A. Shammas, BS, RN¹; Sue Jones-Miller, MS¹; Venkat Shankarraman, PhD²; Michele B. Corbet, MS²

Nicolas W. Shammas, MD, MS1; Gail A....

The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the EX-PAD-03 investigational device exemption study and the Auryon single-center experience...

The Auryon 355-nm laser...

06/17/2022

Journal of Invasive Cardiology

Original Contribution

Auryon Laser in Peripheral Arterial Interventions: A Single-Center Experience (Auryon-SCE)

05/11/2022

Nicolas W. Shammas, MD¹; Gail A Shammas, RN¹; Grace Halupnik, MD¹; Nicholas Fedele, MD¹; Katie Comp, MD¹; Emma-Marie Taleb, MD¹;
Sue Jones-Miller, MD¹; Andrew N. Shammas, MD¹; Venkat Shankarraman, MD²

Nicolas W. Shammas, MD1; Gail A Shamm...

The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...

The Auryon 355-nm laser...

05/11/2022

Journal of Invasive Cardiology

Clinical Experience Using a dACM Construct for the Management of Wounds

03/27/2019

Wounds